Low Tidal Volume Ventilation for Cardiac Surgery
Trial Summary
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Low Tidal Volume Ventilation for Cardiac Surgery?
Research shows that using low tidal volume ventilation, which involves giving smaller breaths to patients on a ventilator, can reduce lung complications and improve outcomes in patients with lung injuries. This approach is also being explored for patients without lung injuries, including those undergoing cardiac surgery, to potentially reduce lung-related complications.12345
Is low tidal volume ventilation generally safe for humans?
How is low tidal volume ventilation unique for cardiac surgery patients?
Low tidal volume ventilation is unique for cardiac surgery patients because it uses smaller breaths to protect the lungs, even in those without lung injury, and can reduce complications after surgery. This approach is different from traditional methods that use larger breaths, and it includes careful control of oxygen levels and pressure to improve outcomes.13568
What is the purpose of this trial?
This is a multi-institutional study (CCF, UPMC, OSU) evaluating different ventilation strategies during cardiopulmonary bypass on mortality and postoperative pulmonary complications, with sub-study investigating 8-iso-prostaglandin F2a and sRAGE levels.
Research Team
Marta Kelava, MD
Principal Investigator
The Cleveland Clinic
Eligibility Criteria
Adults over 18 years old needing elective cardiac surgery with cardiopulmonary bypass can join. It's not for those requiring one-lung ventilation, emergency surgeries, lung or heart transplants, or mechanical circulatory support device implantation.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo cardiopulmonary bypass with different ventilation strategies to evaluate effects on mortality and pulmonary complications
Follow-up
Participants are monitored for postoperative complications and mortality within 30 days of surgery
Sub-study
Sub-study investigates 8-iso-prostaglandin F2a and sRAGE levels during CPB
Treatment Details
Interventions
- Apnea During CPB
- Continuous low-tidal volume ventilation with using FiO2 of 0.21
- Continuous low tidal volume ventilation with using FiO2 of 1.0
Continuous low-tidal volume ventilation with using FiO2 of 0.21 is already approved in United States, European Union, Canada for the following indications:
- Cardiac surgery
- Prevention of postoperative pulmonary complications
- Cardiac surgery
- Prevention of postoperative pulmonary complications
- Acute respiratory distress syndrome
- Cardiac surgery
- Prevention of postoperative pulmonary complications
Find a Clinic Near You
Who Is Running the Clinical Trial?
The Cleveland Clinic
Lead Sponsor
Society of Cardiovascular Anesthesiologists
Collaborator
University of Pittsburgh Medical Center
Collaborator
Ohio State University
Collaborator